Adverse events1,425

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,425

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Pembrolizumab First Course	26	153	32
other	Anaemia	Blood and lymphatic system disorders	Standard of Care (SOC) First Course	33	143	40
other	Anaemia	Blood and lymphatic system disorders	SOC Switched Over to Pembrolizumab	9	57	18
other	Anaemia	Blood and lymphatic system disorders	Pembrolizumab Second Course	1	12	1
other	Anaemia	Blood and lymphatic system disorders	SOC Switched Over to Pembrolizumab-Second Course	0	5	0
other	Leukopenia	Blood and lymphatic system disorders	Pembrolizumab First Course	0	153	0
other	Leukopenia	Blood and lymphatic system disorders	Standard of Care (SOC) First Course	3	143	12
other	Leukopenia	Blood and lymphatic system disorders	SOC Switched Over to Pembrolizumab	0	57	0
other	Leukopenia	Blood and lymphatic system disorders	Pembrolizumab Second Course	0	12	0
other	Leukopenia	Blood and lymphatic system disorders	SOC Switched Over to Pembrolizumab-Second Course	1	5	1
other	Lymphadenopathy	Blood and lymphatic system disorders	Pembrolizumab First Course	0	153	0
other	Lymphadenopathy	Blood and lymphatic system disorders	Standard of Care (SOC) First Course	0	143	0
other	Lymphadenopathy	Blood and lymphatic system disorders	SOC Switched Over to Pembrolizumab	1	57	1
other	Lymphadenopathy	Blood and lymphatic system disorders	Pembrolizumab Second Course	0	12	0
other	Lymphadenopathy	Blood and lymphatic system disorders	SOC Switched Over to Pembrolizumab-Second Course	1	5	1
other	Neutropenia	Blood and lymphatic system disorders	Pembrolizumab First Course	3	153	4
other	Neutropenia	Blood and lymphatic system disorders	Standard of Care (SOC) First Course	27	143	52
other	Neutropenia	Blood and lymphatic system disorders	SOC Switched Over to Pembrolizumab	0	57	0
other	Neutropenia	Blood and lymphatic system disorders	Pembrolizumab Second Course	0	12	0
other	Neutropenia	Blood and lymphatic system disorders	SOC Switched Over to Pembrolizumab-Second Course	0	5	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02563002/events

API reference For AI assistants

Adverse events1,425

Sources 3

Read this list from software.